A
-
Aarskog Syndrome Parents Support Group
-
Abiding Hearts
-
Ablynx
Ablynx, a biopharmaceutical company with headquarters in Ghent, Belgium, is engaged in the discovery and development of Nanobodies® to treat a range of serious human diseases. Nanobodies® are a novel class of antibody-derived therapeutic proteins. Because of their small size, unique structure and extreme stability, Nanobodies® combine the advantages of conventional antibody …
-
About Lymphoma
Blog about Lymphoma
-
About Madelung's
-
Abruzzo-Erickson syndrome
Abruzzo Erickson Syndrome, commonly known as CHARGE syndrome, is a rare genetic disorder. The term CHARGE is actually an acronym to help describe the most common symptoms which can be seen in infants born with this condition.
-
acanthosis-nigricans
Acanthosis nigricans (ak-an-THOE-sis NIE-grih-kuns) is a skin condition characterized by areas of dark, velvety discoloration in body folds and creases. The affected skin can become thickened and may smell bad. Most often, acanthosis nigricans affects your armpits, groin and nec
-
Acardia
Acardiac twins, otherwise known as twin reversed-arterial perfusion (TRAP) sequence, are a rare and serious complication of monochorionic twins
-
Accera Pharma
Accera, a privately held biotechnology company, discovers and develops breakthroughs in treating central nervous systems disorders. Accera’s new and novel therapeutic approaches positively impact patients with neurodegenerative disorders, who are in need of effective, well-tolerated treatments, and their families. Through its proprietary scientific platform, Accera is developing therapies …
-
Achalasia
Achalasia is a disorder of the tube that carries food from the mouth to the stomach (esophagus), which affects the ability of the esophagus to move food toward the stomach.